Pharmacovigilance & drug safety

Pharmacovigilance is the science and detection of drug-related activities, as well as the assessment, comprehension, and prevention of adverse effects or any other drug-related problem. One of the main elements of adverse event reporting is the Individual Case Safety Report.  The triage step of a possible adverse event report is critical in determining whether the "four elements" of a valid ICSR are present, which are an identifiable patient, an identifiable reporter, a suspicious drug, and an adverse event. A variety of strategies are used for signal detection. SD is a crucial component of medication use and safety monitoring. A safety signal is defined by the WHO as "reported information on a causal relationship between an adverse event and a drug, the relationship previously unknown or incompletely documented." A risk management strategy is a recorded plan that discusses the hazards associated with the use of a drug and how they are managed.  The risks reported in an RMP are classified into three types: identifiable risks, possible risks, and unknown risks. Clinical trial reporting, also known as SAE (serious adverse event) reporting from clinical trials, safety information from clinical studies, is used to establish a drug's safety profile in humans and is a key component that drug regulatory authorities consider when deciding whether to grant or deny market authorization for a drug.

    Related Conference of Pharmacovigilance & drug safety

    April 04-05, 2024

    17th European Biosimilars Congress

    Madrid, Spain
    April 11-12, 2024

    5th Annual Congress on Antibiotics and Bacterial Infections

    Amsterdam, Netherlands
    May 09-10, 2024

    4th Global Summit on Pharmaceutical Research

    Barcelona, Spain
    May 16-17, 2024

    18th World Drug Delivery Summit

    Rome, Italy
    May 30-31, 2024

    9th Pharmaceutical Chemistry Conference

    Paris, France
    July 25-26, 2024

    34th Annual European Pharma Congress

    Frankfurt, Germany
    September 11-12, 2024

    9th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    September 25-26, 2024

    4th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2024

    3rd World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2024

    3rd World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 28-29, 2024

    39th World Congress on Pharmacology and Therapeutics

    Paris, France
    November 28-29, 2024

    12th International Conference on Clinical Trials

    Vancouver, Canada
    December 05-06, 2024

    17th World Drug Delivery Summit

    Dubai, UAE

    Pharmacovigilance & drug safety Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in